ID   2A5G_HUMAN              Reviewed;         524 AA.
AC   Q13362; B4DYJ8; B5BUA5; F5GWP3; Q14391; Q15060; Q15174; Q6ZN33;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   07-NOV-2018, entry version 184.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform;
DE   AltName: Full=PP2A B subunit isoform B'-gamma;
DE   AltName: Full=PP2A B subunit isoform B56-gamma;
DE   AltName: Full=PP2A B subunit isoform PR61-gamma;
DE   AltName: Full=PP2A B subunit isoform R5-gamma;
DE   AltName: Full=Renal carcinoma antigen NY-REN-29;
GN   Name=PPP2R5C; Synonyms=KIAA0044;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-3).
RC   TISSUE=Umbilical vein;
RX   PubMed=8617797; DOI=10.1074/jbc.271.9.5164;
RA   Tehrani M.A., Mumby M.C., Kamibayashi C.;
RT   "Identification of a novel protein phosphatase 2A regulatory subunit
RT   highly expressed in muscle.";
RL   J. Biol. Chem. 271:5164-5170(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-1).
RC   TISSUE=Fetal retina;
RX   PubMed=8694763; DOI=10.1042/bj3170187;
RA   Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
RA   Merlevede W., Goris J., Hemmings B.A.;
RT   "The variable subunit associated with protein phosphatase 2A0 defines
RT   a novel multimember family of regulatory subunits.";
RL   Biochem. J. 317:187-194(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND PARTIAL
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Hippocampus, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-3).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-524 (ISOFORM GAMMA-2).
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S.,
RA   Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II.
RT   The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-524 (ISOFORM GAMMA-1).
RX   PubMed=7592815; DOI=10.1074/jbc.270.44.26123;
RA   McCright B., Virshup D.M.;
RT   "Identification of a new family of protein phosphatase 2A regulatory
RT   subunits.";
RL   J. Biol. Chem. 270:26123-26128(1995).
RN   [9]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
RA   McCright B., Rivers A.M., Audlin S., Virshup D.M.;
RT   "The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
RT   encodes differentiation-induced phosphoproteins that target PP2A to
RT   both nucleus and cytoplasm.";
RL   J. Biol. Chem. 271:22081-22089(1996).
RN   [10]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH SGO1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16580887; DOI=10.1016/j.devcel.2006.03.010;
RA   Tang Z., Shu H., Qi W., Mahmood N.A., Mumby M.C., Yu H.;
RT   "PP2A is required for centromeric localization of Sgo1 and proper
RT   chromosome segregation.";
RL   Dev. Cell 10:575-585(2006).
RN   [12]
RP   FUNCTION, INTERACTION WITH IER3 AND ERK KINASES, AND PHOSPHORYLATION.
RX   PubMed=16456541; DOI=10.1038/sj.emboj.7600980;
RA   Letourneux C., Rocher G., Porteu F.;
RT   "B56-containing PP2A dephosphorylate ERK and their activity is
RT   controlled by the early gene IEX-1 and ERK.";
RL   EMBO J. 25:727-738(2006).
RN   [13]
RP   INTERACTION WITH SGO1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [14]
RP   FUNCTION, INTERACTION WITH TP53, AND INDUCTION.
RX   PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
RA   Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
RT   "A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-
RT   induced dephosphorylation of p53 at Thr55.";
RL   EMBO J. 26:402-411(2007).
RN   [15]
RP   INTERACTION WITH TP53.
RX   PubMed=17967874; DOI=10.1128/MCB.00983-07;
RA   Shouse G.P., Cai X., Liu X.;
RT   "Serine 15 phosphorylation of p53 directs its interaction with
RT   B56gamma and the tumor suppressor activity of B56gamma-specific
RT   protein phosphatase 2A.";
RL   Mol. Cell. Biol. 28:448-456(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 1-442 IN COMPLEX WITH PPP2CA
RP   AND PPP2R1A.
RX   PubMed=17174897; DOI=10.1016/j.cell.2006.11.033;
RA   Xu Y., Xing Y., Chen Y., Chao Y., Lin Z., Fan E., Yu J.W., Strack S.,
RA   Jeffrey P.D., Shi Y.;
RT   "Structure of the protein phosphatase 2A holoenzyme.";
RL   Cell 127:1239-1251(2006).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 30-436 IN COMPLEX WITH
RP   PPP2CA AND PPP2R1A.
RX   PubMed=17086192; DOI=10.1038/nature05351;
RA   Cho U.S., Xu W.;
RT   "Crystal structure of a protein phosphatase 2A heterotrimeric
RT   holoenzyme.";
RL   Nature 445:53-57(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 34-436 IN COMPLEX WITH
RP   PPP2CA; PPP2R1A AND SGO1.
RX   PubMed=19716788; DOI=10.1016/j.molcel.2009.06.031;
RA   Xu Z., Cetin B., Anger M., Cho U.S., Helmhart W., Nasmyth K., Xu W.;
RT   "Structure and function of the PP2A-shugoshin interaction.";
RL   Mol. Cell 35:426-441(2009).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 11-380.
RX   PubMed=18618707; DOI=10.1002/prot.22150;
RA   Magnusdottir A., Stenmark P., Flodin S., Nyman T., Kotenyova T.,
RA   Graeslund S., Ogg D., Nordlund P.;
RT   "The structure of the PP2A regulatory subunit B56 gamma: the remaining
RT   piece of the PP2A jigsaw puzzle.";
RL   Proteins 74:212-221(2009).
RN   [21]
RP   INTERACTION WITH CIP2A.
RX   PubMed=28174209; DOI=10.15252/embr.201642788;
RA   Wang J., Okkeri J., Pavic K., Wang Z., Kauko O., Halonen T., Sarek G.,
RA   Ojala P.M., Rao Z., Xu W., Westermarck J.;
RT   "Oncoprotein CIP2A is stabilized via interaction with tumor suppressor
RT   PP2A/B56.";
RL   EMBO Rep. 18:437-450(2017).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment. The PP2A-PPP2R5C holoenzyme may specifically
CC       dephosphorylate and activate TP53 and play a role in DNA damage-
CC       induced inhibition of cell proliferation. PP2A-PPP2R5C may also
CC       regulate the ERK signaling pathway through ERK dephosphorylation.
CC       {ECO:0000269|PubMed:16456541, ECO:0000269|PubMed:17245430}.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and
CC       PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A),
CC       that associates with a variety of regulatory subunits. Proteins
CC       that associate with the core dimer include three families of
CC       regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59
CC       and R5/B'/B56 families), the 48 kDa variable regulatory subunit,
CC       viral proteins, and cell signaling molecules. Interacts with
CC       PPP2CA AND PPP2R1A; the interaction is direct. Interacts with
CC       SGO1; the interaction is direct. Isoform 1 and isoform 2 interact
CC       with TP53 (phosphorylated at Ser-15 by ATM); increased upon DNA
CC       damage it drives PP2A-mediated dephosphorylation of TP53 at Thr-
CC       55. Interacts with IER3 and/or ERK kinases; regulates ERK
CC       dephosphorylation. Interacts with CIP2A; this interaction
CC       stabilizes CIP2A (PubMed:28174209). {ECO:0000269|PubMed:16456541,
CC       ECO:0000269|PubMed:16541025, ECO:0000269|PubMed:16580887,
CC       ECO:0000269|PubMed:17086192, ECO:0000269|PubMed:17174897,
CC       ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:17967874,
CC       ECO:0000269|PubMed:19716788, ECO:0000269|PubMed:28174209}.
CC   -!- INTERACTION:
CC       O96017:CHEK2; NbExp=4; IntAct=EBI-1266176, EBI-1180783;
CC       P46695:IER3; NbExp=2; IntAct=EBI-1266156, EBI-1748945;
CC       Q00987:MDM2; NbExp=5; IntAct=EBI-1266156, EBI-389668;
CC       P67775:PPP2CA; NbExp=9; IntAct=EBI-1266156, EBI-712311;
CC       P30153:PPP2R1A; NbExp=10; IntAct=EBI-1266156, EBI-302388;
CC       P30154:PPP2R1B; NbExp=2; IntAct=EBI-1266156, EBI-357094;
CC       P04049:RAF1; NbExp=2; IntAct=EBI-1266156, EBI-365996;
CC       P04637:TP53; NbExp=4; IntAct=EBI-1266156, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=Gamma-3;
CC         IsoId=Q13362-1; Sequence=Displayed;
CC       Name=Gamma-1;
CC         IsoId=Q13362-2; Sequence=VSP_005112;
CC       Name=Gamma-2;
CC         IsoId=Q13362-3; Sequence=VSP_005113;
CC       Name=4;
CC         IsoId=Q13362-4; Sequence=VSP_043645, VSP_005113;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q13362-5; Sequence=VSP_046768;
CC         Note=Ref.3 (BAG63760) sequence is in conflict in position:
CC         3:N->K. No experimental confirmation available. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Highest levels in heart, skeletal muscle and
CC       brain. Lower levels in pancreas, kidney, lung and placenta. Very
CC       low levels in liver.
CC   -!- INDUCTION: Up-regulated upon DNA damage.
CC       {ECO:0000269|PubMed:17245430}.
CC   -!- PTM: Isoform Gamma-3 is phosphorylated on serine residues. Isoform
CC       Gamma-1 phosphorylation by ERK2 is IER3-dependent and inhibits ERK
CC       dephosphorylation by PP2A-PPP2R5C. {ECO:0000269|PubMed:16456541,
CC       ECO:0000269|PubMed:8703017}.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50387.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG63760.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U37352; AAC50387.1; ALT_INIT; mRNA.
DR   EMBL; Z69030; CAA93154.1; -; mRNA.
DR   EMBL; AK131391; BAD18542.1; -; mRNA.
DR   EMBL; AK302470; BAG63760.1; ALT_INIT; mRNA.
DR   EMBL; AB451341; BAG70155.1; -; mRNA.
DR   EMBL; AL118558; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81756.1; -; Genomic_DNA.
DR   EMBL; D26445; BAA05465.1; -; mRNA.
DR   EMBL; L42375; AAC37603.1; -; mRNA.
DR   CCDS; CCDS45163.1; -. [Q13362-2]
DR   CCDS; CCDS53911.1; -. [Q13362-4]
DR   CCDS; CCDS53912.1; -. [Q13362-5]
DR   CCDS; CCDS9964.1; -. [Q13362-1]
DR   CCDS; CCDS9965.1; -. [Q13362-3]
DR   RefSeq; NP_001155197.1; NM_001161725.1. [Q13362-5]
DR   RefSeq; NP_001155198.1; NM_001161726.1. [Q13362-4]
DR   RefSeq; NP_002710.2; NM_002719.3. [Q13362-1]
DR   RefSeq; NP_848701.1; NM_178586.2. [Q13362-3]
DR   RefSeq; NP_848702.1; NM_178587.2. [Q13362-2]
DR   RefSeq; XP_005267884.1; XM_005267827.1.
DR   RefSeq; XP_011535222.1; XM_011536920.1.
DR   UniGene; Hs.368264; -.
DR   PDB; 2IAE; X-ray; 3.50 A; B/E=30-436.
DR   PDB; 2JAK; X-ray; 2.60 A; A=11-380.
DR   PDB; 2NPP; X-ray; 3.30 A; B/E=1-442.
DR   PDB; 2NYL; X-ray; 3.80 A; B/E=38-425.
DR   PDB; 2NYM; X-ray; 3.60 A; B/E=38-425.
DR   PDB; 3FGA; X-ray; 2.70 A; B=34-436.
DR   PDB; 5JJA; X-ray; 2.35 A; A/B=30-380.
DR   PDB; 5K6S; X-ray; 2.79 A; A=31-380.
DR   PDB; 5SW9; X-ray; 2.85 A; A=31-380.
DR   PDB; 5SWF; X-ray; 2.82 A; A=31-380.
DR   PDBsum; 2IAE; -.
DR   PDBsum; 2JAK; -.
DR   PDBsum; 2NPP; -.
DR   PDBsum; 2NYL; -.
DR   PDBsum; 2NYM; -.
DR   PDBsum; 3FGA; -.
DR   PDBsum; 5JJA; -.
DR   PDBsum; 5K6S; -.
DR   PDBsum; 5SW9; -.
DR   PDBsum; 5SWF; -.
DR   ProteinModelPortal; Q13362; -.
DR   SMR; Q13362; -.
DR   BioGrid; 111519; 43.
DR   DIP; DIP-39401N; -.
DR   ELM; Q13362; -.
DR   IntAct; Q13362; 21.
DR   MINT; Q13362; -.
DR   STRING; 9606.ENSP00000412324; -.
DR   iPTMnet; Q13362; -.
DR   PhosphoSitePlus; Q13362; -.
DR   BioMuta; PPP2R5C; -.
DR   DMDM; 116241235; -.
DR   EPD; Q13362; -.
DR   MaxQB; Q13362; -.
DR   PaxDb; Q13362; -.
DR   PeptideAtlas; Q13362; -.
DR   PRIDE; Q13362; -.
DR   DNASU; 5527; -.
DR   Ensembl; ENST00000328724; ENSP00000329009; ENSG00000078304. [Q13362-4]
DR   Ensembl; ENST00000334743; ENSP00000333905; ENSG00000078304. [Q13362-1]
DR   Ensembl; ENST00000350249; ENSP00000262239; ENSG00000078304. [Q13362-3]
DR   Ensembl; ENST00000422945; ENSP00000412324; ENSG00000078304. [Q13362-5]
DR   Ensembl; ENST00000445439; ENSP00000408389; ENSG00000078304. [Q13362-2]
DR   GeneID; 5527; -.
DR   KEGG; hsa:5527; -.
DR   UCSC; uc001ykk.4; human. [Q13362-1]
DR   CTD; 5527; -.
DR   DisGeNET; 5527; -.
DR   EuPathDB; HostDB:ENSG00000078304.19; -.
DR   GeneCards; PPP2R5C; -.
DR   HGNC; HGNC:9311; PPP2R5C.
DR   HPA; HPA027553; -.
DR   MIM; 601645; gene.
DR   neXtProt; NX_Q13362; -.
DR   OpenTargets; ENSG00000078304; -.
DR   PharmGKB; PA33674; -.
DR   eggNOG; KOG2085; Eukaryota.
DR   eggNOG; ENOG410XQJW; LUCA.
DR   GeneTree; ENSGT00550000074525; -.
DR   HOGENOM; HOG000067326; -.
DR   HOVERGEN; HBG000009; -.
DR   InParanoid; Q13362; -.
DR   KO; K11584; -.
DR   OMA; SHCRADE; -.
DR   OrthoDB; EOG091G06HU; -.
DR   PhylomeDB; Q13362; -.
DR   TreeFam; TF105556; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-196299; Beta-catenin phosphorylation cascade.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-HSA-432142; Platelet sensitization by LDL.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-HSA-5339716; Misspliced GSK3beta mutants stabilize beta-catenin.
DR   Reactome; R-HSA-5358747; S33 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358749; S37 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358751; S45 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358752; T41 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5467337; APC truncation mutants have impaired AXIN binding.
DR   Reactome; R-HSA-5467340; AXIN missense mutants destabilize the destruction complex.
DR   Reactome; R-HSA-5467348; Truncations of AMER1 destabilize the destruction complex.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SignaLink; Q13362; -.
DR   SIGNOR; Q13362; -.
DR   ChiTaRS; PPP2R5C; human.
DR   EvolutionaryTrace; Q13362; -.
DR   GeneWiki; PPP2R5C; -.
DR   GenomeRNAi; 5527; -.
DR   PMAP-CutDB; Q13362; -.
DR   PRO; PR:Q13362; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000078304; Expressed in 232 organ(s), highest expression level in sperm.
DR   CleanEx; HS_PPP2R5C; -.
DR   ExpressionAtlas; Q13362; baseline and differential.
DR   Genevisible; Q13362; HS.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0072542; F:protein phosphatase activator activity; IBA:GO_Central.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IDA:UniProtKB.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:MGI.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002554; PP2A_B56.
DR   PANTHER; PTHR10257; PTHR10257; 1.
DR   Pfam; PF01603; B56; 1.
DR   PIRSF; PIRSF028043; PP2A_B56; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Centromere;
KW   Chromosome; Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    524       Serine/threonine-protein phosphatase 2A
FT                                56 kDa regulatory subunit gamma isoform.
FT                                /FTId=PRO_0000071457.
FT   MOTIF       416    422       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       1     31       MLTCNKAGSRMVVDAANSNGPFQPVVLLHIR -> MPNKNK
FT                                KEKESPKAGKSGKSSKEGQDTVESEQISVRKNSLVAVPSTV
FT                                SAKIKVPVSQPIVKKDKRQNSSRFSASNNRELQKLPSLK
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043645.
FT   VAR_SEQ       1     30       MLTCNKAGSRMVVDAANSNGPFQPVVLLHI -> MPNKNKK
FT                                EKESPKAGKSGKSSKEGQDTVESEGTSPEEPSSPKVPPPLL
FT                                PELLVLIFGGLQG (in isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_046768.
FT   VAR_SEQ     443    524       YTVYSQASTMSIPVAMETDGPLFEDVQMLRKTVKDEAHQAQ
FT                                KDPKKDRPLARRKSELPQDPHTKKALEAHCRADELASQDGR
FT                                -> VLKKRIT (in isoform Gamma-1).
FT                                {ECO:0000303|PubMed:7592815,
FT                                ECO:0000303|PubMed:8694763}.
FT                                /FTId=VSP_005112.
FT   VAR_SEQ     443    481       Missing (in isoform Gamma-2 and isoform
FT                                4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:7584044}.
FT                                /FTId=VSP_005113.
FT   VARIANT     515    515       A -> P (in dbSNP:rs3742424).
FT                                /FTId=VAR_051745.
FT   CONFLICT    494    494       R -> L (in Ref. 1; AAC50387).
FT                                {ECO:0000305}.
FT   HELIX        30     32       {ECO:0000244|PDB:5JJA}.
FT   TURN         35     37       {ECO:0000244|PDB:5JJA}.
FT   HELIX        38     48       {ECO:0000244|PDB:5JJA}.
FT   STRAND       55     57       {ECO:0000244|PDB:5JJA}.
FT   TURN         59     62       {ECO:0000244|PDB:5JJA}.
FT   HELIX        63     82       {ECO:0000244|PDB:5JJA}.
FT   STRAND       83     85       {ECO:0000244|PDB:5SWF}.
FT   HELIX        91    103       {ECO:0000244|PDB:5JJA}.
FT   STRAND      115    118       {ECO:0000244|PDB:2NPP}.
FT   HELIX       120    122       {ECO:0000244|PDB:3FGA}.
FT   HELIX       131    146       {ECO:0000244|PDB:5JJA}.
FT   HELIX       152    155       {ECO:0000244|PDB:5JJA}.
FT   TURN        156    158       {ECO:0000244|PDB:5JJA}.
FT   HELIX       161    169       {ECO:0000244|PDB:5JJA}.
FT   HELIX       170    172       {ECO:0000244|PDB:5JJA}.
FT   HELIX       176    192       {ECO:0000244|PDB:5JJA}.
FT   HELIX       194    196       {ECO:0000244|PDB:5JJA}.
FT   HELIX       197    213       {ECO:0000244|PDB:5JJA}.
FT   HELIX       221    233       {ECO:0000244|PDB:5JJA}.
FT   HELIX       241    249       {ECO:0000244|PDB:5JJA}.
FT   TURN        250    252       {ECO:0000244|PDB:5JJA}.
FT   HELIX       253    256       {ECO:0000244|PDB:5JJA}.
FT   HELIX       260    262       {ECO:0000244|PDB:5JJA}.
FT   HELIX       264    277       {ECO:0000244|PDB:5JJA}.
FT   HELIX       279    281       {ECO:0000244|PDB:5JJA}.
FT   HELIX       282    292       {ECO:0000244|PDB:5JJA}.
FT   HELIX       301    313       {ECO:0000244|PDB:5JJA}.
FT   HELIX       317    335       {ECO:0000244|PDB:5JJA}.
FT   HELIX       340    347       {ECO:0000244|PDB:5JJA}.
FT   HELIX       348    351       {ECO:0000244|PDB:5JJA}.
FT   HELIX       353    360       {ECO:0000244|PDB:5JJA}.
FT   HELIX       363    370       {ECO:0000244|PDB:5JJA}.
FT   TURN        372    374       {ECO:0000244|PDB:5JJA}.
FT   HELIX       384    398       {ECO:0000244|PDB:3FGA}.
FT   HELIX       409    430       {ECO:0000244|PDB:3FGA}.
SQ   SEQUENCE   524 AA;  61061 MW;  B9CBF54550D713F8 CRC64;
     MLTCNKAGSR MVVDAANSNG PFQPVVLLHI RDVPPADQEK LFIQKLRQCC VLFDFVSDPL
     SDLKWKEVKR AALSEMVEYI THNRNVITEP IYPEVVHMFA VNMFRTLPPS SNPTGAEFDP
     EEDEPTLEAA WPHLQLVYEF FLRFLESPDF QPNIAKKYID QKFVLQLLEL FDSEDPRERD
     FLKTTLHRIY GKFLGLRAYI RKQINNIFYR FIYETEHHNG IAELLEILGS IINGFALPLK
     EEHKIFLLKV LLPLHKVKSL SVYHPQLAYC VVQFLEKDST LTEPVVMALL KYWPKTHSPK
     EVMFLNELEE ILDVIEPSEF VKIMEPLFRQ LAKCVSSPHF QVAERALYYW NNEYIMSLIS
     DNAAKILPIM FPSLYRNSKT HWNKTIHGLI YNALKLFMEM NQKLFDDCTQ QFKAEKLKEK
     LKMKEREEAW VKIENLAKAN PQYTVYSQAS TMSIPVAMET DGPLFEDVQM LRKTVKDEAH
     QAQKDPKKDR PLARRKSELP QDPHTKKALE AHCRADELAS QDGR
//
